BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36972052)

  • 1. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
    Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
    JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
    JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.
    Romskaug R; Skovlund E; Straand J; Molden E; Kersten H; Pitkala KH; Lundqvist C; Wyller TB
    JAMA Intern Med; 2020 Feb; 180(2):181-189. PubMed ID: 31617562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
    McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
    J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial.
    Rieckert A; Reeves D; Altiner A; Drewelow E; Esmail A; Flamm M; Hann M; Johansson T; Klaassen-Mielke R; Kunnamo I; Löffler C; Piccoliori G; Sommerauer C; Trampisch US; Vögele A; Woodham A; Sönnichsen A
    BMJ; 2020 Jun; 369():m1822. PubMed ID: 32554566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
    McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
    PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria.
    Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D
    J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial.
    Jamieson H; Nishtala PS; Bergler HU; Weaver SK; Pickering JW; Ailabouni NJ; Abey-Nesbit R; Gullery C; Deely J; Gee SB; Hilmer SN; Mangin D
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1692-1700. PubMed ID: 36692224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
    Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
    J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
    Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
    BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.